Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Preliminary data from an open-label, Dutch Phase I trial in 36 healthy volunteers showed that ICLL's TB vaccine was safe and stimulated a strong immunogenic T cell response. ...